Products for Research Use Only
RegisterLogin

Adebrelimab

CAT: 0804-HY-P99422-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99422-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) [1][2].
CAS Number
2247114-85-6
Product Name Alternative
SHR-1316
UNSPSC
12352203
Target
Apoptosis; PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/adebrelimab.html
Purity
97.84
Solubility
10 mM in DMSO
Smiles
[Adebrelimab]
Molecular Weight
(145.56 kDa)
References & Citations
[1]Zhiwei Liu, et al. The Synergistic Effects of Pyrotinib and SHR-1316 on HER2-positve breast cancer. Research Square. May 19th, 2022.|[2]Wanpu Yan, et al. Adebrelimab (SHR-1316) in combination with chemotherapy as perioperative treatment in patients with resectable stage II-III NSCLC: an open-label, multicenter, phase 1b trial. J Thorac Oncol. 2022 Sep 30; S1556-0864 (22) 01822-6.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 4

Alternative Products

CatalogName
abx831789-01Adebrelimab
GTR18337874-01Adebrelimab Antibody
E55B0443Adebrelimab (Reference antibody)
HV974086-01Research Grade Adebrelimab
ICH5225-50mgAdebrelimab Biosimilar - Research Grade
GTR18780129-01(Adebrelimab) Biosimilar Reference Antibody
A138296Adebrelimab Biosimilar (Monoclonal, IgG4)
GTR18697760-01Adebrelimab Human Monoclonal Antibody
PX-TA1806-d-01Adebrelimab Biosimilar - Research Grade mAb
RA0081-01Adebrelimab (Biosimilar Reference Antibody) (CD274)

Popular Products